Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 15.08 is 100% above its 5-year average of 7.53, around the middle of its 5-year range (1.50–21.68).
As of the fiscal period ended Tuesday, June 30, 2026. 4.02% above its 12-month average of 14.49.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.08.
CURRENT RATIO
15.08
CURRENT RATIO AVG TTM
14.49
CURRENT RATIO AVG 3Y
8.41
CURRENT RATIO AVG 5Y
7.53
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.02%
CURRENT VS 3Y AVG
+79.27%
CURRENT VS 5Y AVG
+100.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
+333.25%
vs the sector median at left
Market Cap
$1.95B
Current Ratio
3.84
TTM Avg
3.30
3Y Avg
3.38
5Y Avg
3.69
Market Cap
$2.00B
Current Ratio
8.55
TTM Avg
6.61
3Y Avg
7.37
5Y Avg
8.17
Market Cap
$2.03B
Current Ratio
5.42
TTM Avg
4.91
3Y Avg
6.23
5Y Avg
8.44
Market Cap
$2.03B
Current Ratio
34.46
TTM Avg
28.89
3Y Avg
23.88
5Y Avg
16.33
Market Cap
$1.90B
Current Ratio
10.22
TTM Avg
11.68
3Y Avg
12.23
5Y Avg
12.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.97B | 15.08 | 14.49 | 8.41 | 7.53 |
| AxoGen, Inc. (AXGN)vs › | $1.96B | 6.60 | 4.18 | 3.84 | 4.49 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | 3.84 | 3.30 | 3.38 | 3.69 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 8.55 | 6.61 | 7.37 | 8.17 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 5.42 | 4.91 | 6.23 | 8.44 |
| Progyny, Inc. (PGNY)vs › | $2.03B | 2.14 | 2.76 | 2.92 | 2.79 |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.03B | 34.46 | 28.89 | 23.88 | 16.33 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | 10.22 | 11.68 | 12.23 | 12.24 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Novavax, Inc. (NVAX)vs › | $1.87B | 2.33 | 1.55 | 1.13 | 1.26 |
Current Ratio
15.08
Quick Ratio
15.08
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 15.08 |
| 2026-03-31 | 21.68 |
| 2025-12-31 | 14.69 |
| 2025-09-30 | 8.90 |
| 2025-06-30 | 12.13 |
| 2025-03-31 | 10.49 |
| 2024-12-31 | 4.08 |
| 2024-09-30 | 6.17 |
| 2024-06-30 | 7.12 |
| 2024-03-31 | 10.18 |
| 2023-12-31 | 6.63 |
| 2023-09-30 | 3.96 |
| 2023-06-30 | 1.50 |
| 2023-03-31 | 1.87 |
| 2022-12-31 | 3.09 |
| 2022-09-30 | 3.97 |
| 2022-06-30 | 4.36 |
| 2022-03-31 | 4.77 |
| 2021-12-31 | 5.82 |
| 2021-09-30 | 7.88 |
| 2021-06-30 | 17.84 |
| 2021-03-31 | 8.99 |
| 2020-12-31 | 14.12 |
| 2020-09-30 | 1.38 |
| 2020-06-30 | 3.65 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.88 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
